Skip Navigation

Home>About VRMNY>Our Physicians & Staff>Jason S. Slakter, MD

Our Physicians & Staff

Jason S. Slakter, MD

Jason S. Slakter, MDJason S. Slakter, M.D., is a board certified retinal and macular disease specialist, who practices and is a partner at the Vitreous–Retina–Macula Consultants of New York, N.Y. In addition, he is a Clinical Professor of Ophthalmology at New York University School of Medicine.

Dr. Slakter is a nationally and internationally recognized retinal specialist who has been involved in the design and application of a variety of diagnostic and therapeutic techniques. He has played a key role in the clinical development of digital indocyanine green angiography (ICG), particularly for the evaluation of macular degeneration and chorioretinal inflammatory disease. He has published more than 80 papers and book chapters. He also is an author of the first comprehensive text on the subject of ICG angiography.

Dr. Slakter’s chief research interests relate to the management of exudative age–related macular degeneration, retinal vascular disease and central serous chorioretinopathy. He has served as a principal investigator in many of the pivotal clinical trials for these diseases and is currently conducting clinical studies related to a number of macular conditions. He created and is the director of the Digital Angiography Reading Center, which has become one of the world’s largest image evaluation organizations, serving as a key resource for industry-sponsored studies of new treatments for retinal disorders. He is on the medical advisory boards and serves as a consultant to many of the biotechnology and pharmaceutical companies involved in the development of new treatments for AMD, diabetic retinopathy and retinal vascular disease.

Dr. Slakter is a member of numerous medical organizations including The Macula Society, The Retina Society, The American Society of Retina Specialists, and the New York Opthalmological Society. He is the Editor–in–Chief of Retinal Physician, is on the editorial board of Retina and serves as a scientific reviewer for all of the major scientific ophthalmic journals.

Dr. Slakter is the recipient of many awards. In 1999, he received the American Academy of Ophthalmology Honor Award. He also has received The Macula Society’s Richard and Hinda Rosenthal Award for outstanding contribution to the treatment of ocular disease by an individual under the age of 45, as well as the Helen Keller Manhattan League Award in 2003. Dr. Slakter also received a Senior Honor Award from the American Academy of Ophthalmology at the 2004 annual meeting.